Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls.
AUTOR(ES)
Austin, A K
RESUMO
Cartilage link protein of high purity was prepared and used in an enzyme linked immunosorbent assay (ELISA). Antibodies to link protein were sought in the sera of 98 patients with rheumatic disorders; 38 with rheumatoid arthritis (RA), 29 with osteoarthritis (OA), 13 with psoriatic arthritis (PA), nine with ankylosing spondylitis (AS), nine with systemic lupus erythematosus (SLE), and in 83 healthy controls. Antibodies were detected in all groups with the following prevalences: 21/83 normals, 9/38 RA, 7/29 OA, 7/13 PA, 3/9 AS, and 4/9 SLE. No statistically significant differences existed between the groups with regard to either prevalence or mean titre of anti-link antibodies. Serum antibodies to proteoglycan link protein appear to be no more common in patients with rheumatic disorders than in healthy controls.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003626Documentos Relacionados
- Cellular immunity to cartilage link protein in patients with inflammatory arthritis and non-arthritic controls.
- Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls.
- Comparison of urinary glycosaminoglycan excretion in rheumatoid arthritis, osteoarthritis, myocardial infarction, and controls.
- Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases
- Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls.
